Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 05 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Long-acting Reversible Contraceptives (LARCs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Long-acting Reversible Contraceptives (LARCs) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-acting Reversible Contraceptives (LARCs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Reversible Contraceptives (LARCs) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Long-acting Reversible Contraceptives (LARCs) total production and demand, 2018-2029, (K Units)
Global Long-acting Reversible Contraceptives (LARCs) total production value, 2018-2029, (USD Million)
Global Long-acting Reversible Contraceptives (LARCs) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Long-acting Reversible Contraceptives (LARCs) domestic production, consumption, key domestic manufacturers and share
Global Long-acting Reversible Contraceptives (LARCs) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Long-acting Reversible Contraceptives (LARCs) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Reversible Contraceptives (LARCs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-acting Reversible Contraceptives (LARCs) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Long-acting Reversible Contraceptives (LARCs) Market, Segmentation by Type
Hormonal Intrauterine Devices
Copper Intrauterine Devices
Contraceptive Implants
Others

Global Long-acting Reversible Contraceptives (LARCs) Market, Segmentation by Application
Age 20-24
Age 25-34
Age 35-44
Others

Companies Profiled:
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON

Key Questions Answered
1. How big is the global Long-acting Reversible Contraceptives (LARCs) market?
2. What is the demand of the global Long-acting Reversible Contraceptives (LARCs) market?
3. What is the year over year growth of the global Long-acting Reversible Contraceptives (LARCs) market?
4. What is the production and production value of the global Long-acting Reversible Contraceptives (LARCs) market?
5. Who are the key producers in the global Long-acting Reversible Contraceptives (LARCs) market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Long-acting Reversible Contraceptives (LARCs) Introduction
1.2 World Long-acting Reversible Contraceptives (LARCs) Supply & Forecast
1.2.1 World Long-acting Reversible Contraceptives (LARCs) Production Value (2018 & 2022 & 2029)
1.2.2 World Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.2.3 World Long-acting Reversible Contraceptives (LARCs) Pricing Trends (2018-2029)
1.3 World Long-acting Reversible Contraceptives (LARCs) Production by Region (Based on Production Site)
1.3.1 World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018-2029)
1.3.2 World Long-acting Reversible Contraceptives (LARCs) Production by Region (2018-2029)
1.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2018-2029)
1.3.4 North America Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.5 Europe Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.6 China Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.7 Japan Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-acting Reversible Contraceptives (LARCs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-acting Reversible Contraceptives (LARCs) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Long-acting Reversible Contraceptives (LARCs) Demand (2018-2029)
2.2 World Long-acting Reversible Contraceptives (LARCs) Consumption by Region
2.2.1 World Long-acting Reversible Contraceptives (LARCs) Consumption by Region (2018-2023)
2.2.2 World Long-acting Reversible Contraceptives (LARCs) Consumption Forecast by Region (2024-2029)
2.3 United States Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.4 China Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.5 Europe Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.6 Japan Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.7 South Korea Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.8 ASEAN Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.9 India Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)

3 World Long-acting Reversible Contraceptives (LARCs) Manufacturers Competitive Analysis
3.1 World Long-acting Reversible Contraceptives (LARCs) Production Value by Manufacturer (2018-2023)
3.2 World Long-acting Reversible Contraceptives (LARCs) Production by Manufacturer (2018-2023)
3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2018-2023)
3.4 Long-acting Reversible Contraceptives (LARCs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-acting Reversible Contraceptives (LARCs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-acting Reversible Contraceptives (LARCs) in 2022
3.5.3 Global Concentration Ratios (CR8) for Long-acting Reversible Contraceptives (LARCs) in 2022
3.6 Long-acting Reversible Contraceptives (LARCs) Market: Overall Company Footprint Analysis
3.6.1 Long-acting Reversible Contraceptives (LARCs) Market: Region Footprint
3.6.2 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
3.6.3 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Comparison
4.1.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Comparison
4.2.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Comparison
4.3.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)
4.5 China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share
4.5.1 China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.5.3 China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)
4.6 Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)

5 Market Analysis by Type
5.1 World Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hormonal Intrauterine Devices
5.2.2 Copper Intrauterine Devices
5.2.3 Contraceptive Implants
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Long-acting Reversible Contraceptives (LARCs) Production by Type (2018-2029)
5.3.2 World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2018-2029)
5.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Age 20-24
6.2.2 Age 25-34
6.2.3 Age 35-44
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Long-acting Reversible Contraceptives (LARCs) Production by Application (2018-2029)
6.3.2 World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2018-2029)
6.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
7.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
7.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Cooper Companies
7.3.1 Cooper Companies Details
7.3.2 Cooper Companies Major Business
7.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
7.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cooper Companies Recent Developments/Updates
7.3.6 Cooper Companies Competitive Strengths & Weaknesses
7.4 AbbVie Allergan
7.4.1 AbbVie Allergan Details
7.4.2 AbbVie Allergan Major Business
7.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
7.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AbbVie Allergan Recent Developments/Updates
7.4.6 AbbVie Allergan Competitive Strengths & Weaknesses
7.5 Yantai JiShengYaoXie
7.5.1 Yantai JiShengYaoXie Details
7.5.2 Yantai JiShengYaoXie Major Business
7.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
7.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Yantai JiShengYaoXie Recent Developments/Updates
7.5.6 Yantai JiShengYaoXie Competitive Strengths & Weaknesses
7.6 H & J Medical
7.6.1 H & J Medical Details
7.6.2 H & J Medical Major Business
7.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
7.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 H & J Medical Recent Developments/Updates
7.6.6 H & J Medical Competitive Strengths & Weaknesses
7.7 HRA Pharma
7.7.1 HRA Pharma Details
7.7.2 HRA Pharma Major Business
7.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
7.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 HRA Pharma Recent Developments/Updates
7.7.6 HRA Pharma Competitive Strengths & Weaknesses
7.8 Pregna
7.8.1 Pregna Details
7.8.2 Pregna Major Business
7.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
7.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pregna Recent Developments/Updates
7.8.6 Pregna Competitive Strengths & Weaknesses
7.9 ASPIVIX
7.9.1 ASPIVIX Details
7.9.2 ASPIVIX Major Business
7.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
7.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 ASPIVIX Recent Developments/Updates
7.9.6 ASPIVIX Competitive Strengths & Weaknesses
7.10 Shanghai Dahua Pharmaceuticals
7.10.1 Shanghai Dahua Pharmaceuticals Details
7.10.2 Shanghai Dahua Pharmaceuticals Major Business
7.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
7.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
7.10.6 Shanghai Dahua Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Williams Medical Supplies
7.11.1 Williams Medical Supplies Details
7.11.2 Williams Medical Supplies Major Business
7.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
7.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Williams Medical Supplies Recent Developments/Updates
7.11.6 Williams Medical Supplies Competitive Strengths & Weaknesses
7.12 Laboratoire 7 MED
7.12.1 Laboratoire 7 MED Details
7.12.2 Laboratoire 7 MED Major Business
7.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
7.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Laboratoire 7 MED Recent Developments/Updates
7.12.6 Laboratoire 7 MED Competitive Strengths & Weaknesses
7.13 Durbin
7.13.1 Durbin Details
7.13.2 Durbin Major Business
7.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
7.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Durbin Recent Developments/Updates
7.13.6 Durbin Competitive Strengths & Weaknesses
7.14 Laboratoire CCD
7.14.1 Laboratoire CCD Details
7.14.2 Laboratoire CCD Major Business
7.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
7.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Laboratoire CCD Recent Developments/Updates
7.14.6 Laboratoire CCD Competitive Strengths & Weaknesses
7.15 Prosan
7.15.1 Prosan Details
7.15.2 Prosan Major Business
7.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
7.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Prosan Recent Developments/Updates
7.15.6 Prosan Competitive Strengths & Weaknesses
7.16 OCON
7.16.1 OCON Details
7.16.2 OCON Major Business
7.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
7.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 OCON Recent Developments/Updates
7.16.6 OCON Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Long-acting Reversible Contraceptives (LARCs) Industry Chain
8.2 Long-acting Reversible Contraceptives (LARCs) Upstream Analysis
8.2.1 Long-acting Reversible Contraceptives (LARCs) Core Raw Materials
8.2.2 Main Manufacturers of Long-acting Reversible Contraceptives (LARCs) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Long-acting Reversible Contraceptives (LARCs) Production Mode
8.6 Long-acting Reversible Contraceptives (LARCs) Procurement Model
8.7 Long-acting Reversible Contraceptives (LARCs) Industry Sales Model and Sales Channels
8.7.1 Long-acting Reversible Contraceptives (LARCs) Sales Model
8.7.2 Long-acting Reversible Contraceptives (LARCs) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2018-2023)
Table 5. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2024-2029)
Table 6. World Long-acting Reversible Contraceptives (LARCs) Production by Region (2018-2023) & (K Units)
Table 7. World Long-acting Reversible Contraceptives (LARCs) Production by Region (2024-2029) & (K Units)
Table 8. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2018-2023)
Table 9. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2024-2029)
Table 10. World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Long-acting Reversible Contraceptives (LARCs) Major Market Trends
Table 13. World Long-acting Reversible Contraceptives (LARCs) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Long-acting Reversible Contraceptives (LARCs) Consumption by Region (2018-2023) & (K Units)
Table 15. World Long-acting Reversible Contraceptives (LARCs) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Long-acting Reversible Contraceptives (LARCs) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Long-acting Reversible Contraceptives (LARCs) Producers in 2022
Table 18. World Long-acting Reversible Contraceptives (LARCs) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Long-acting Reversible Contraceptives (LARCs) Producers in 2022
Table 20. World Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Long-acting Reversible Contraceptives (LARCs) Company Evaluation Quadrant
Table 22. World Long-acting Reversible Contraceptives (LARCs) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Long-acting Reversible Contraceptives (LARCs) Production Site of Key Manufacturer
Table 24. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
Table 25. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
Table 26. Long-acting Reversible Contraceptives (LARCs) Competitive Factors
Table 27. Long-acting Reversible Contraceptives (LARCs) New Entrant and Capacity Expansion Plans
Table 28. Long-acting Reversible Contraceptives (LARCs) Mergers & Acquisitions Activity
Table 29. United States VS China Long-acting Reversible Contraceptives (LARCs) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Long-acting Reversible Contraceptives (LARCs) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Long-acting Reversible Contraceptives (LARCs) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 37. China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 42. Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 47. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Long-acting Reversible Contraceptives (LARCs) Production by Type (2018-2023) & (K Units)
Table 49. World Long-acting Reversible Contraceptives (LARCs) Production by Type (2024-2029) & (K Units)
Table 50. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Long-acting Reversible Contraceptives (LARCs) Production by Application (2018-2023) & (K Units)
Table 56. World Long-acting Reversible Contraceptives (LARCs) Production by Application (2024-2029) & (K Units)
Table 57. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 64. Bayer Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 70. Merck Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 74. Cooper Companies Major Business
Table 75. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 76. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cooper Companies Recent Developments/Updates
Table 78. Cooper Companies Competitive Strengths & Weaknesses
Table 79. AbbVie Allergan Basic Information, Manufacturing Base and Competitors
Table 80. AbbVie Allergan Major Business
Table 81. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 82. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AbbVie Allergan Recent Developments/Updates
Table 84. AbbVie Allergan Competitive Strengths & Weaknesses
Table 85. Yantai JiShengYaoXie Basic Information, Manufacturing Base and Competitors
Table 86. Yantai JiShengYaoXie Major Business
Table 87. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 88. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yantai JiShengYaoXie Recent Developments/Updates
Table 90. Yantai JiShengYaoXie Competitive Strengths & Weaknesses
Table 91. H & J Medical Basic Information, Manufacturing Base and Competitors
Table 92. H & J Medical Major Business
Table 93. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 94. H & J Medical Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. H & J Medical Recent Developments/Updates
Table 96. H & J Medical Competitive Strengths & Weaknesses
Table 97. HRA Pharma Basic Information, Manufacturing Base and Competitors
Table 98. HRA Pharma Major Business
Table 99. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 100. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. HRA Pharma Recent Developments/Updates
Table 102. HRA Pharma Competitive Strengths & Weaknesses
Table 103. Pregna Basic Information, Manufacturing Base and Competitors
Table 104. Pregna Major Business
Table 105. Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 106. Pregna Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pregna Recent Developments/Updates
Table 108. Pregna Competitive Strengths & Weaknesses
Table 109. ASPIVIX Basic Information, Manufacturing Base and Competitors
Table 110. ASPIVIX Major Business
Table 111. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 112. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. ASPIVIX Recent Developments/Updates
Table 114. ASPIVIX Competitive Strengths & Weaknesses
Table 115. Shanghai Dahua Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Dahua Pharmaceuticals Major Business
Table 117. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 118. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shanghai Dahua Pharmaceuticals Recent Developments/Updates
Table 120. Shanghai Dahua Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Williams Medical Supplies Basic Information, Manufacturing Base and Competitors
Table 122. Williams Medical Supplies Major Business
Table 123. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 124. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Williams Medical Supplies Recent Developments/Updates
Table 126. Williams Medical Supplies Competitive Strengths & Weaknesses
Table 127. Laboratoire 7 MED Basic Information, Manufacturing Base and Competitors
Table 128. Laboratoire 7 MED Major Business
Table 129. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 130. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Laboratoire 7 MED Recent Developments/Updates
Table 132. Laboratoire 7 MED Competitive Strengths & Weaknesses
Table 133. Durbin Basic Information, Manufacturing Base and Competitors
Table 134. Durbin Major Business
Table 135. Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 136. Durbin Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Durbin Recent Developments/Updates
Table 138. Durbin Competitive Strengths & Weaknesses
Table 139. Laboratoire CCD Basic Information, Manufacturing Base and Competitors
Table 140. Laboratoire CCD Major Business
Table 141. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 142. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Laboratoire CCD Recent Developments/Updates
Table 144. Laboratoire CCD Competitive Strengths & Weaknesses
Table 145. Prosan Basic Information, Manufacturing Base and Competitors
Table 146. Prosan Major Business
Table 147. Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 148. Prosan Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Prosan Recent Developments/Updates
Table 150. OCON Basic Information, Manufacturing Base and Competitors
Table 151. OCON Major Business
Table 152. OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 153. OCON Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Long-acting Reversible Contraceptives (LARCs) Upstream (Raw Materials)
Table 155. Long-acting Reversible Contraceptives (LARCs) Typical Customers
Table 156. Long-acting Reversible Contraceptives (LARCs) Typical Distributors
List of Figure
Figure 1. Long-acting Reversible Contraceptives (LARCs) Picture
Figure 2. World Long-acting Reversible Contraceptives (LARCs) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Long-acting Reversible Contraceptives (LARCs) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 5. World Long-acting Reversible Contraceptives (LARCs) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2018-2029)
Figure 7. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2018-2029)
Figure 8. North America Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 9. Europe Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 10. China Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 11. Japan Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 12. Long-acting Reversible Contraceptives (LARCs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 15. World Long-acting Reversible Contraceptives (LARCs) Consumption Market Share by Region (2018-2029)
Figure 16. United States Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 17. China Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 18. Europe Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 19. Japan Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 22. India Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Long-acting Reversible Contraceptives (LARCs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting Reversible Contraceptives (LARCs) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting Reversible Contraceptives (LARCs) Markets in 2022
Figure 26. United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 30. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 32. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Type in 2022
Figure 34. Hormonal Intrauterine Devices
Figure 35. Copper Intrauterine Devices
Figure 36. Contraceptive Implants
Figure 37. Others
Figure 38. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Type (2018-2029)
Figure 39. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Type (2018-2029)
Figure 40. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Application in 2022
Figure 43. Age 20-24
Figure 44. Age 25-34
Figure 45. Age 35-44
Figure 46. Others
Figure 47. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Application (2018-2029)
Figure 48. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Application (2018-2029)
Figure 49. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Long-acting Reversible Contraceptives (LARCs) Industry Chain
Figure 51. Long-acting Reversible Contraceptives (LARCs) Procurement Model
Figure 52. Long-acting Reversible Contraceptives (LARCs) Sales Model
Figure 53. Long-acting Reversible Contraceptives (LARCs) Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

Global Long-acting Reversible Contraceptives (LARCs) Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 05 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Long-acting Reversible Contraceptives (LARCs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Long-acting Reversible Contraceptives (LARCs) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-acting Reversible Contraceptives (LARCs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Reversible Contraceptives (LARCs) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Long-acting Reversible Contraceptives (LARCs) total production and demand, 2018-2029, (K Units)
Global Long-acting Reversible Contraceptives (LARCs) total production value, 2018-2029, (USD Million)
Global Long-acting Reversible Contraceptives (LARCs) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Long-acting Reversible Contraceptives (LARCs) domestic production, consumption, key domestic manufacturers and share
Global Long-acting Reversible Contraceptives (LARCs) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting Reversible Contraceptives (LARCs) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Long-acting Reversible Contraceptives (LARCs) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Reversible Contraceptives (LARCs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-acting Reversible Contraceptives (LARCs) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Long-acting Reversible Contraceptives (LARCs) Market, Segmentation by Type
Hormonal Intrauterine Devices
Copper Intrauterine Devices
Contraceptive Implants
Others

Global Long-acting Reversible Contraceptives (LARCs) Market, Segmentation by Application
Age 20-24
Age 25-34
Age 35-44
Others

Companies Profiled:
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON

Key Questions Answered
1. How big is the global Long-acting Reversible Contraceptives (LARCs) market?
2. What is the demand of the global Long-acting Reversible Contraceptives (LARCs) market?
3. What is the year over year growth of the global Long-acting Reversible Contraceptives (LARCs) market?
4. What is the production and production value of the global Long-acting Reversible Contraceptives (LARCs) market?
5. Who are the key producers in the global Long-acting Reversible Contraceptives (LARCs) market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Long-acting Reversible Contraceptives (LARCs) Introduction
1.2 World Long-acting Reversible Contraceptives (LARCs) Supply & Forecast
1.2.1 World Long-acting Reversible Contraceptives (LARCs) Production Value (2018 & 2022 & 2029)
1.2.2 World Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.2.3 World Long-acting Reversible Contraceptives (LARCs) Pricing Trends (2018-2029)
1.3 World Long-acting Reversible Contraceptives (LARCs) Production by Region (Based on Production Site)
1.3.1 World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018-2029)
1.3.2 World Long-acting Reversible Contraceptives (LARCs) Production by Region (2018-2029)
1.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2018-2029)
1.3.4 North America Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.5 Europe Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.6 China Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.3.7 Japan Long-acting Reversible Contraceptives (LARCs) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-acting Reversible Contraceptives (LARCs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-acting Reversible Contraceptives (LARCs) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Long-acting Reversible Contraceptives (LARCs) Demand (2018-2029)
2.2 World Long-acting Reversible Contraceptives (LARCs) Consumption by Region
2.2.1 World Long-acting Reversible Contraceptives (LARCs) Consumption by Region (2018-2023)
2.2.2 World Long-acting Reversible Contraceptives (LARCs) Consumption Forecast by Region (2024-2029)
2.3 United States Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.4 China Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.5 Europe Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.6 Japan Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.7 South Korea Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.8 ASEAN Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)
2.9 India Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029)

3 World Long-acting Reversible Contraceptives (LARCs) Manufacturers Competitive Analysis
3.1 World Long-acting Reversible Contraceptives (LARCs) Production Value by Manufacturer (2018-2023)
3.2 World Long-acting Reversible Contraceptives (LARCs) Production by Manufacturer (2018-2023)
3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2018-2023)
3.4 Long-acting Reversible Contraceptives (LARCs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-acting Reversible Contraceptives (LARCs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-acting Reversible Contraceptives (LARCs) in 2022
3.5.3 Global Concentration Ratios (CR8) for Long-acting Reversible Contraceptives (LARCs) in 2022
3.6 Long-acting Reversible Contraceptives (LARCs) Market: Overall Company Footprint Analysis
3.6.1 Long-acting Reversible Contraceptives (LARCs) Market: Region Footprint
3.6.2 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
3.6.3 Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Comparison
4.1.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Comparison
4.2.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Comparison
4.3.1 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)
4.5 China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share
4.5.1 China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.5.3 China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)
4.6 Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023)

5 Market Analysis by Type
5.1 World Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Hormonal Intrauterine Devices
5.2.2 Copper Intrauterine Devices
5.2.3 Contraceptive Implants
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Long-acting Reversible Contraceptives (LARCs) Production by Type (2018-2029)
5.3.2 World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2018-2029)
5.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Age 20-24
6.2.2 Age 25-34
6.2.3 Age 35-44
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Long-acting Reversible Contraceptives (LARCs) Production by Application (2018-2029)
6.3.2 World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2018-2029)
6.3.3 World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
7.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
7.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Cooper Companies
7.3.1 Cooper Companies Details
7.3.2 Cooper Companies Major Business
7.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
7.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cooper Companies Recent Developments/Updates
7.3.6 Cooper Companies Competitive Strengths & Weaknesses
7.4 AbbVie Allergan
7.4.1 AbbVie Allergan Details
7.4.2 AbbVie Allergan Major Business
7.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
7.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AbbVie Allergan Recent Developments/Updates
7.4.6 AbbVie Allergan Competitive Strengths & Weaknesses
7.5 Yantai JiShengYaoXie
7.5.1 Yantai JiShengYaoXie Details
7.5.2 Yantai JiShengYaoXie Major Business
7.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
7.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Yantai JiShengYaoXie Recent Developments/Updates
7.5.6 Yantai JiShengYaoXie Competitive Strengths & Weaknesses
7.6 H & J Medical
7.6.1 H & J Medical Details
7.6.2 H & J Medical Major Business
7.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
7.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 H & J Medical Recent Developments/Updates
7.6.6 H & J Medical Competitive Strengths & Weaknesses
7.7 HRA Pharma
7.7.1 HRA Pharma Details
7.7.2 HRA Pharma Major Business
7.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
7.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 HRA Pharma Recent Developments/Updates
7.7.6 HRA Pharma Competitive Strengths & Weaknesses
7.8 Pregna
7.8.1 Pregna Details
7.8.2 Pregna Major Business
7.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
7.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pregna Recent Developments/Updates
7.8.6 Pregna Competitive Strengths & Weaknesses
7.9 ASPIVIX
7.9.1 ASPIVIX Details
7.9.2 ASPIVIX Major Business
7.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
7.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 ASPIVIX Recent Developments/Updates
7.9.6 ASPIVIX Competitive Strengths & Weaknesses
7.10 Shanghai Dahua Pharmaceuticals
7.10.1 Shanghai Dahua Pharmaceuticals Details
7.10.2 Shanghai Dahua Pharmaceuticals Major Business
7.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
7.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
7.10.6 Shanghai Dahua Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Williams Medical Supplies
7.11.1 Williams Medical Supplies Details
7.11.2 Williams Medical Supplies Major Business
7.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
7.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Williams Medical Supplies Recent Developments/Updates
7.11.6 Williams Medical Supplies Competitive Strengths & Weaknesses
7.12 Laboratoire 7 MED
7.12.1 Laboratoire 7 MED Details
7.12.2 Laboratoire 7 MED Major Business
7.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
7.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Laboratoire 7 MED Recent Developments/Updates
7.12.6 Laboratoire 7 MED Competitive Strengths & Weaknesses
7.13 Durbin
7.13.1 Durbin Details
7.13.2 Durbin Major Business
7.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
7.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Durbin Recent Developments/Updates
7.13.6 Durbin Competitive Strengths & Weaknesses
7.14 Laboratoire CCD
7.14.1 Laboratoire CCD Details
7.14.2 Laboratoire CCD Major Business
7.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
7.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Laboratoire CCD Recent Developments/Updates
7.14.6 Laboratoire CCD Competitive Strengths & Weaknesses
7.15 Prosan
7.15.1 Prosan Details
7.15.2 Prosan Major Business
7.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
7.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Prosan Recent Developments/Updates
7.15.6 Prosan Competitive Strengths & Weaknesses
7.16 OCON
7.16.1 OCON Details
7.16.2 OCON Major Business
7.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
7.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 OCON Recent Developments/Updates
7.16.6 OCON Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Long-acting Reversible Contraceptives (LARCs) Industry Chain
8.2 Long-acting Reversible Contraceptives (LARCs) Upstream Analysis
8.2.1 Long-acting Reversible Contraceptives (LARCs) Core Raw Materials
8.2.2 Main Manufacturers of Long-acting Reversible Contraceptives (LARCs) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Long-acting Reversible Contraceptives (LARCs) Production Mode
8.6 Long-acting Reversible Contraceptives (LARCs) Procurement Model
8.7 Long-acting Reversible Contraceptives (LARCs) Industry Sales Model and Sales Channels
8.7.1 Long-acting Reversible Contraceptives (LARCs) Sales Model
8.7.2 Long-acting Reversible Contraceptives (LARCs) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Long-acting Reversible Contraceptives (LARCs) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2018-2023)
Table 5. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2024-2029)
Table 6. World Long-acting Reversible Contraceptives (LARCs) Production by Region (2018-2023) & (K Units)
Table 7. World Long-acting Reversible Contraceptives (LARCs) Production by Region (2024-2029) & (K Units)
Table 8. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2018-2023)
Table 9. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2024-2029)
Table 10. World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Long-acting Reversible Contraceptives (LARCs) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Long-acting Reversible Contraceptives (LARCs) Major Market Trends
Table 13. World Long-acting Reversible Contraceptives (LARCs) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Long-acting Reversible Contraceptives (LARCs) Consumption by Region (2018-2023) & (K Units)
Table 15. World Long-acting Reversible Contraceptives (LARCs) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Long-acting Reversible Contraceptives (LARCs) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Long-acting Reversible Contraceptives (LARCs) Producers in 2022
Table 18. World Long-acting Reversible Contraceptives (LARCs) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Long-acting Reversible Contraceptives (LARCs) Producers in 2022
Table 20. World Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Long-acting Reversible Contraceptives (LARCs) Company Evaluation Quadrant
Table 22. World Long-acting Reversible Contraceptives (LARCs) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Long-acting Reversible Contraceptives (LARCs) Production Site of Key Manufacturer
Table 24. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Type Footprint
Table 25. Long-acting Reversible Contraceptives (LARCs) Market: Company Product Application Footprint
Table 26. Long-acting Reversible Contraceptives (LARCs) Competitive Factors
Table 27. Long-acting Reversible Contraceptives (LARCs) New Entrant and Capacity Expansion Plans
Table 28. Long-acting Reversible Contraceptives (LARCs) Mergers & Acquisitions Activity
Table 29. United States VS China Long-acting Reversible Contraceptives (LARCs) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Long-acting Reversible Contraceptives (LARCs) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Long-acting Reversible Contraceptives (LARCs) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 37. China Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 42. Rest of World Based Long-acting Reversible Contraceptives (LARCs) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share (2018-2023)
Table 47. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Long-acting Reversible Contraceptives (LARCs) Production by Type (2018-2023) & (K Units)
Table 49. World Long-acting Reversible Contraceptives (LARCs) Production by Type (2024-2029) & (K Units)
Table 50. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Long-acting Reversible Contraceptives (LARCs) Production by Application (2018-2023) & (K Units)
Table 56. World Long-acting Reversible Contraceptives (LARCs) Production by Application (2024-2029) & (K Units)
Table 57. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 64. Bayer Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 70. Merck Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 74. Cooper Companies Major Business
Table 75. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 76. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cooper Companies Recent Developments/Updates
Table 78. Cooper Companies Competitive Strengths & Weaknesses
Table 79. AbbVie Allergan Basic Information, Manufacturing Base and Competitors
Table 80. AbbVie Allergan Major Business
Table 81. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 82. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AbbVie Allergan Recent Developments/Updates
Table 84. AbbVie Allergan Competitive Strengths & Weaknesses
Table 85. Yantai JiShengYaoXie Basic Information, Manufacturing Base and Competitors
Table 86. Yantai JiShengYaoXie Major Business
Table 87. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 88. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yantai JiShengYaoXie Recent Developments/Updates
Table 90. Yantai JiShengYaoXie Competitive Strengths & Weaknesses
Table 91. H & J Medical Basic Information, Manufacturing Base and Competitors
Table 92. H & J Medical Major Business
Table 93. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 94. H & J Medical Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. H & J Medical Recent Developments/Updates
Table 96. H & J Medical Competitive Strengths & Weaknesses
Table 97. HRA Pharma Basic Information, Manufacturing Base and Competitors
Table 98. HRA Pharma Major Business
Table 99. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 100. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. HRA Pharma Recent Developments/Updates
Table 102. HRA Pharma Competitive Strengths & Weaknesses
Table 103. Pregna Basic Information, Manufacturing Base and Competitors
Table 104. Pregna Major Business
Table 105. Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 106. Pregna Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pregna Recent Developments/Updates
Table 108. Pregna Competitive Strengths & Weaknesses
Table 109. ASPIVIX Basic Information, Manufacturing Base and Competitors
Table 110. ASPIVIX Major Business
Table 111. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 112. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. ASPIVIX Recent Developments/Updates
Table 114. ASPIVIX Competitive Strengths & Weaknesses
Table 115. Shanghai Dahua Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Shanghai Dahua Pharmaceuticals Major Business
Table 117. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 118. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Shanghai Dahua Pharmaceuticals Recent Developments/Updates
Table 120. Shanghai Dahua Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Williams Medical Supplies Basic Information, Manufacturing Base and Competitors
Table 122. Williams Medical Supplies Major Business
Table 123. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 124. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Williams Medical Supplies Recent Developments/Updates
Table 126. Williams Medical Supplies Competitive Strengths & Weaknesses
Table 127. Laboratoire 7 MED Basic Information, Manufacturing Base and Competitors
Table 128. Laboratoire 7 MED Major Business
Table 129. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 130. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Laboratoire 7 MED Recent Developments/Updates
Table 132. Laboratoire 7 MED Competitive Strengths & Weaknesses
Table 133. Durbin Basic Information, Manufacturing Base and Competitors
Table 134. Durbin Major Business
Table 135. Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 136. Durbin Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Durbin Recent Developments/Updates
Table 138. Durbin Competitive Strengths & Weaknesses
Table 139. Laboratoire CCD Basic Information, Manufacturing Base and Competitors
Table 140. Laboratoire CCD Major Business
Table 141. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 142. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Laboratoire CCD Recent Developments/Updates
Table 144. Laboratoire CCD Competitive Strengths & Weaknesses
Table 145. Prosan Basic Information, Manufacturing Base and Competitors
Table 146. Prosan Major Business
Table 147. Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 148. Prosan Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Prosan Recent Developments/Updates
Table 150. OCON Basic Information, Manufacturing Base and Competitors
Table 151. OCON Major Business
Table 152. OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
Table 153. OCON Long-acting Reversible Contraceptives (LARCs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Long-acting Reversible Contraceptives (LARCs) Upstream (Raw Materials)
Table 155. Long-acting Reversible Contraceptives (LARCs) Typical Customers
Table 156. Long-acting Reversible Contraceptives (LARCs) Typical Distributors
List of Figure
Figure 1. Long-acting Reversible Contraceptives (LARCs) Picture
Figure 2. World Long-acting Reversible Contraceptives (LARCs) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Long-acting Reversible Contraceptives (LARCs) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 5. World Long-acting Reversible Contraceptives (LARCs) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Region (2018-2029)
Figure 7. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Region (2018-2029)
Figure 8. North America Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 9. Europe Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 10. China Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 11. Japan Long-acting Reversible Contraceptives (LARCs) Production (2018-2029) & (K Units)
Figure 12. Long-acting Reversible Contraceptives (LARCs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 15. World Long-acting Reversible Contraceptives (LARCs) Consumption Market Share by Region (2018-2029)
Figure 16. United States Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 17. China Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 18. Europe Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 19. Japan Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 22. India Long-acting Reversible Contraceptives (LARCs) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Long-acting Reversible Contraceptives (LARCs) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting Reversible Contraceptives (LARCs) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting Reversible Contraceptives (LARCs) Markets in 2022
Figure 26. United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Long-acting Reversible Contraceptives (LARCs) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Long-acting Reversible Contraceptives (LARCs) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 30. China Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Long-acting Reversible Contraceptives (LARCs) Production Market Share 2022
Figure 32. World Long-acting Reversible Contraceptives (LARCs) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Type in 2022
Figure 34. Hormonal Intrauterine Devices
Figure 35. Copper Intrauterine Devices
Figure 36. Contraceptive Implants
Figure 37. Others
Figure 38. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Type (2018-2029)
Figure 39. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Type (2018-2029)
Figure 40. World Long-acting Reversible Contraceptives (LARCs) Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Long-acting Reversible Contraceptives (LARCs) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Application in 2022
Figure 43. Age 20-24
Figure 44. Age 25-34
Figure 45. Age 35-44
Figure 46. Others
Figure 47. World Long-acting Reversible Contraceptives (LARCs) Production Market Share by Application (2018-2029)
Figure 48. World Long-acting Reversible Contraceptives (LARCs) Production Value Market Share by Application (2018-2029)
Figure 49. World Long-acting Reversible Contraceptives (LARCs) Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Long-acting Reversible Contraceptives (LARCs) Industry Chain
Figure 51. Long-acting Reversible Contraceptives (LARCs) Procurement Model
Figure 52. Long-acting Reversible Contraceptives (LARCs) Sales Model
Figure 53. Long-acting Reversible Contraceptives (LARCs) Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now